CorMedix Inc. (CRMD) Stock Price

CRMDStock

$7.26−27.98%52W

Market Cap$565.88M

P/E3.47x

PEG Ratio5.20

Div yield—

Beta1.47

CRMD Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-10.45%

Price vs S&P 500 (4W)-5.24%

PEG Ratio5.20

VGM Score75.28

P/E Ratio (Annual)3.47x

P/CF (Annual)3.23x

Book Value / Share (Quarterly)$5.93

P/TBV (Annual)34.93x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)1545.19%

Cash Flow / Share (Quarterly)$3.22

Price vs S&P 500 (YTD)-49.50%

Gross Margin (TTM)82.78%

Net Profit Margin (TTM)40.49%

EPS (TTM)$2.10

10-Day Avg Trading Volume1.18M

EPS Excl Extra (TTM)$2.10

Revenue Growth (5Y)319.48%

EPS (Annual)$2.03

ROI (Annual)29.59%

Gross Margin (Annual)88.46%

Net Profit Margin (5Y Avg)-13288.81%

Cash / Share (Quarterly)$3.31

P/E Basic Excl Extra (TTM)3.02x

Revenue Growth QoQ (YoY)156.52%

P/E Normalized (Annual)3.47x

ROA (Last FY)19.74%

Revenue Growth TTM (YoY)280.50%

EBITD / Share (TTM)$2.61

ROE (5Y Avg)-29.17%

Operating Margin (TTM)46.95%

Cash Flow / Share (Annual)$2.18

P/B Ratio1.23x

P/B Ratio (Quarterly)1.34x

Net Income / Employee (Annual)$853,700

EV / Revenue (TTM)0.98x

Net Interest Coverage (TTM)-1472.00x

ROA (TTM)22.71%

EPS Growth QoQ (YoY)1.92%

EV / EBITDA (TTM)1.90x

EPS Incl Extra (Annual)$2.03

Current Ratio (Annual)2.11x

Quick Ratio (Quarterly)2.23x

3-Month Avg Trading Volume1.18M

52-Week Price Return-27.98%

EV / Free Cash Flow (Annual)2.63x

P/E Incl Extra (TTM)3.02x

Revenue / Employee (TTM)$2,420,100

Tangible BV / Share (Quarterly)$1.32

P/S Ratio (Annual)1.82x

Asset Turnover (Annual)0.38x

52-Week High$13.02

Operating Margin (5Y Avg)-14116.51%

EPS Excl Extra (Annual)$2.03

CapEx CAGR (5Y)83.04%

Tangible BV CAGR (5Y)50.24%

26-Week Price Return-0.55%

Quick Ratio (Annual)1.87x

13-Week Price Return-13.78%

Total Debt / Equity (Annual)0.36x

Current Ratio (Quarterly)2.56x

Enterprise Value$454.33M

Revenue / Share Growth (5Y)241.15%

Asset Turnover (TTM)0.56x

Book Value / Share Growth (5Y)31.16%

Revenue / Employee (Annual)$1,632,000

Inventory Turnover (Annual)1.93x

Pretax Margin (Annual)48.13%

Cash / Share (Annual)$1.87

3-Month Return Std Dev49.19%

Gross Margin (5Y Avg)60.08%

Net Income / Employee (TTM)$980,000

ROE (Last FY)40.23%

Net Interest Coverage (Annual)16.69x

EPS Basic Excl Extra (Annual)$2.03

P/FCF (TTM)2.26x

Receivables Turnover (TTM)4.53x

EV / Free Cash Flow (TTM)1.81x

Total Debt / Equity (Quarterly)0.32x

EPS Incl Extra (TTM)$2.10

Receivables Turnover (Annual)2.80x

ROI (TTM)33.15%

P/S Ratio (TTM)1.22x

Pretax Margin (5Y Avg)-14021.27%

Revenue / Share (Annual)$3.88

Tangible BV / Share (Annual)$0.33

Forward P/E42.63x

Price vs S&P 500 (52W)-43.51%

P/E Ratio (TTM)3.02x

EPS Growth TTM (YoY)181.82%

Year-to-Date Return-37.58%

5-Day Price Return-2.68%

EPS Normalized (Annual)$2.03

ROA (5Y Avg)-28.12%

Net Profit Margin (Annual)52.31%

Month-to-Date Return-5.71%

Cash Flow / Share (TTM)$-0.85

EBITD / Share (Annual)$1.88

Operating Margin (Annual)48.17%

LT Debt / Equity (Annual)0.36x

P/CF (TTM)2.23x

ROI (5Y Avg)-31.30%

P/E Excl Extra (TTM)3.02x

LT Debt / Equity (Quarterly)0.32x

EPS Basic Excl Extra (TTM)$2.10

P/TBV (Quarterly)6.02x

P/B Ratio (Annual)2.26x

Inventory Turnover (TTM)3.30x

Pretax Margin (TTM)44.00%

Book Value / Share (Annual)$5.11

Price vs S&P 500 (13W)-16.46%

Beta1.47x

P/FCF (Annual)3.27x

Revenue / Share (TTM)$5.00

ROE (TTM)44.64%

52-Week Low$6.13

vGradeA

gGradeA

mGradeC

vgmGradeB

CRMD Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 13, 2026	$0.24	$0.29	+21.85%(+$0.05)
Q1 2026	May 14, 2026	$0.33	$0.35	+5.91%(+$0.02)
Q4 2025	Mar 5, 2026	$0.81	$0.16	-80.24%(-$0.65)
Q3 2025	Nov 12, 2025	$0.63	$1.41	+121.67%(+$0.77)
Q2 2025	Aug 7, 2025	$0.19	$0.28	+49.62%(+$0.09)

CRMD Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.17

4.18

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
CRMDCorMedix Inc.	A	A	C	1.2x	280.5%	82.8%	—	$7.26
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About CorMedix Inc.

Cormedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases. The company's primary product, DefenCath, is being marketed in the United States and other key markets.